Vanta Bioscience has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 10, 2017 at 2:30 PM at the registered office of the Company, to consider and approve the unaudited financial results of the Company for the half year ended September 30, 2017; and to discuss any other matter as may be decided by the Board. In this connection, the trading window for dealing in the securities of the Company will remain closed for designated persons from November 03, 2017 to November 12, 2017.
The above information is a part of company’s filings submitted to BSE.